Arkolith/Insider Trading/ELTP/Form 4

Hakim Nasrat A

CEO & President, Director, 10% OwnerELITE PHARMACEUTICALS INC /NV/ (ELTP) · full profile →Form 4 · filed Aug 26, 2020
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 24, 2020Conversion(C)158.0M—$0167.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 24, 2020Conversion(C)24—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001583742-20-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for ELITE PHARMACEUTICALS INC /NV/

Build

Ask your agent about ELTP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001583742-20-000002"
Ask your agent
Use Arkolith to summarize insider buying and selling at ELITE PHARMACEUTICALS INC /NV/
over the last 90 days and cite the filings.